Background: TNE-GEPs are rare and originate in the endocrine system located in the gastrointestinal tract (carcinoids) and in the pancreas (island tumours) with a variety of clinical presentations. Design: Cooperative, retrospective. Method: Between January 2005 and December 2018, a cooperative work in the Central Guard Service of the HNC, General Surgery Service "Pablo Luis Mirizzi" of the HNC and Caraffa Private Clinic, 24 patients with TNE-GEP were surgically intervened. Of the total, 14 belonged to the female sex (58.3%) and the remaining 10 men (41.6%), with an age range between 20 and 82 years of age with an average of 55.3 years. Results: The locations were 4 stomachs (16.6%), 14 in the intestine (58.3%) and finally 6 in the head of the pancreas (25%). In relation to the stomach in the 4 patients a total gastrectomy was performed and the pathological anatomy in three demonstrated low-grade neuroendocrine carcinoma and the fourth high degree, the latter dying. 5 patients with clinical presentations of acute appendicitis. The pathological anatomy was further acute appendicitis, a low-grade neuroendocrine carcinoma. In ileum-cecal region, four of it performed right colectomy. In three were low-grade living and fourth high-grade carcinoma with liver mtts who died. In three of the ileum all were occlusive, carrying out intestinal resections, in two low- and last-grade moderate-grade carcinomas with living liver mtts. The colon tumours were, one ascending with hepatic mtts and right colectomy more liver resections, with pathological anatomy being high-grade carcinoma and another a low-grade descending colon. The 6 pancreas lesions, 3 were non-functioning and three other functioning. All patients were operated of CPD. Conclusion: TNE-GEP is a rare pathology but whose frequency is constant onset. With improved imaging methods, we are faced with an increase in preoperative presumption and in the face of its best oncological possibilities, a pathology that every surgeon must know and think about.
Published in | Cancer Research Journal (Volume 9, Issue 4) |
DOI | 10.11648/j.crj.20210904.13 |
Page(s) | 196-201 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
TNE-GEPs Are Rare, Endocrine System Located in the Gastrointestinal Tract, Surgical Treatment
[1] | Klöppel G, Rindi G, Anlauf M, et al (2007).: Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors. Virchows Arch. 451: 9-27. |
[2] | Kourie HR, Ghorra C, Rassy M, et al (2016).: Digestive Neuroendocrine Tumour Distribution and Characteristics According to the 2010 WHO Classification: a Single Institution Experience in Lebanon. Asian. Pac. J. Cancer. Prev. 17 (5): 2679-2681. |
[3] | Rindi G (2010).: The ENETS guidelines: the new TNM classification system. Tumori. 96: 806-809. |
[4] | Scoazec JY, Couvelard A (2011).: The new WHO classification if digestive neuroendocrine tumors. Ann Pathol. 31: 88-92. |
[5] | Kloppel G. (2011): Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms. Endocr. Relat. Cancer. 18: 1-16. |
[6] | Massironi S, Sciola V, Peracchi M, et al (2008).: Neuroendocrine tumors of the gastro-entero-pancreatic system. World. J. Gastroenterol. 14 (35): 5377-5384. |
[7] | Williams ED, Sandler M (1963): The classification of carcinoid tumor’s. Lancet. 1: 238-239. |
[8] | Klimstra DS, Modlin IR, Coppola D, et al (2010).: The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging Systems. Pancreas. 39 (6): 707-712. |
[9] | Solcia E, Klöppel G, Sobin LH (2000). Histological Typing of Endocrine Tumors. WHO International Histological Classification of Tumors. 2nd ed. Berlin: Springer: 56-70. |
[10] | Brighi N, La Rosa S, Rossi G, Grillo F Pusceddu S, Rinzivillo M, et al (2020): Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix: A Multicentric Retrospective Study. Ann. Surg. 271 (3): 527-533. |
[11] | Mullen JT, Savarese DMF.: Carcinoid tumors of the appendix: a populationbased study. J. Surg. Oncol. 2011. 104: 41–44. |
[12] | Wu L, Fu J, Wan L, Pan J, Lai S, Zhong J, et al (2017).: Survival outcomes and surgical intervention of small intestinal neuroendocrine tumors: a population based retrospective study. Oncotarget. Vol. 8 (3): 4935-4947. |
[13] | Bösch F, Bruewer K, D'Anastasi M, Guba M, Werner J, Angele MK, et al (2018).: Neuroendocrine tumours of the small intestine causing a desmoplastic reaction of the mesentery are a more aggressive cohort. Surgery 164 (5): 1093-1099. |
[14] | Northrop JA, Lee JH (2007).: Large Bowel Carcinoid Tumours. Curr. Opin. Gastroenterol. 23 (1): 74-78. |
[15] | Calvo Hernán F, Ortiz Bellver v, Berenguer Lapuerta J (2002).: Tumor y síndrome carcinoide. Revis Gastroenterol. 4: 219 – 226. |
APA Style
Paul Eduardo Lada, Casares Gonzalo, Mariot Daniela, Janikow Christian, Saliba Jorge, et al. (2021). Neuroendocrine Tumours of Gastrointestinal Tract: Our Experience. Cancer Research Journal, 9(4), 196-201. https://doi.org/10.11648/j.crj.20210904.13
ACS Style
Paul Eduardo Lada; Casares Gonzalo; Mariot Daniela; Janikow Christian; Saliba Jorge, et al. Neuroendocrine Tumours of Gastrointestinal Tract: Our Experience. Cancer Res. J. 2021, 9(4), 196-201. doi: 10.11648/j.crj.20210904.13
AMA Style
Paul Eduardo Lada, Casares Gonzalo, Mariot Daniela, Janikow Christian, Saliba Jorge, et al. Neuroendocrine Tumours of Gastrointestinal Tract: Our Experience. Cancer Res J. 2021;9(4):196-201. doi: 10.11648/j.crj.20210904.13
@article{10.11648/j.crj.20210904.13, author = {Paul Eduardo Lada and Casares Gonzalo and Mariot Daniela and Janikow Christian and Saliba Jorge and Martínez Julián and Santiago Carrizo and Abril Giménez and Francisco Flórez}, title = {Neuroendocrine Tumours of Gastrointestinal Tract: Our Experience}, journal = {Cancer Research Journal}, volume = {9}, number = {4}, pages = {196-201}, doi = {10.11648/j.crj.20210904.13}, url = {https://doi.org/10.11648/j.crj.20210904.13}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.crj.20210904.13}, abstract = {Background: TNE-GEPs are rare and originate in the endocrine system located in the gastrointestinal tract (carcinoids) and in the pancreas (island tumours) with a variety of clinical presentations. Design: Cooperative, retrospective. Method: Between January 2005 and December 2018, a cooperative work in the Central Guard Service of the HNC, General Surgery Service "Pablo Luis Mirizzi" of the HNC and Caraffa Private Clinic, 24 patients with TNE-GEP were surgically intervened. Of the total, 14 belonged to the female sex (58.3%) and the remaining 10 men (41.6%), with an age range between 20 and 82 years of age with an average of 55.3 years. Results: The locations were 4 stomachs (16.6%), 14 in the intestine (58.3%) and finally 6 in the head of the pancreas (25%). In relation to the stomach in the 4 patients a total gastrectomy was performed and the pathological anatomy in three demonstrated low-grade neuroendocrine carcinoma and the fourth high degree, the latter dying. 5 patients with clinical presentations of acute appendicitis. The pathological anatomy was further acute appendicitis, a low-grade neuroendocrine carcinoma. In ileum-cecal region, four of it performed right colectomy. In three were low-grade living and fourth high-grade carcinoma with liver mtts who died. In three of the ileum all were occlusive, carrying out intestinal resections, in two low- and last-grade moderate-grade carcinomas with living liver mtts. The colon tumours were, one ascending with hepatic mtts and right colectomy more liver resections, with pathological anatomy being high-grade carcinoma and another a low-grade descending colon. The 6 pancreas lesions, 3 were non-functioning and three other functioning. All patients were operated of CPD. Conclusion: TNE-GEP is a rare pathology but whose frequency is constant onset. With improved imaging methods, we are faced with an increase in preoperative presumption and in the face of its best oncological possibilities, a pathology that every surgeon must know and think about.}, year = {2021} }
TY - JOUR T1 - Neuroendocrine Tumours of Gastrointestinal Tract: Our Experience AU - Paul Eduardo Lada AU - Casares Gonzalo AU - Mariot Daniela AU - Janikow Christian AU - Saliba Jorge AU - Martínez Julián AU - Santiago Carrizo AU - Abril Giménez AU - Francisco Flórez Y1 - 2021/12/24 PY - 2021 N1 - https://doi.org/10.11648/j.crj.20210904.13 DO - 10.11648/j.crj.20210904.13 T2 - Cancer Research Journal JF - Cancer Research Journal JO - Cancer Research Journal SP - 196 EP - 201 PB - Science Publishing Group SN - 2330-8214 UR - https://doi.org/10.11648/j.crj.20210904.13 AB - Background: TNE-GEPs are rare and originate in the endocrine system located in the gastrointestinal tract (carcinoids) and in the pancreas (island tumours) with a variety of clinical presentations. Design: Cooperative, retrospective. Method: Between January 2005 and December 2018, a cooperative work in the Central Guard Service of the HNC, General Surgery Service "Pablo Luis Mirizzi" of the HNC and Caraffa Private Clinic, 24 patients with TNE-GEP were surgically intervened. Of the total, 14 belonged to the female sex (58.3%) and the remaining 10 men (41.6%), with an age range between 20 and 82 years of age with an average of 55.3 years. Results: The locations were 4 stomachs (16.6%), 14 in the intestine (58.3%) and finally 6 in the head of the pancreas (25%). In relation to the stomach in the 4 patients a total gastrectomy was performed and the pathological anatomy in three demonstrated low-grade neuroendocrine carcinoma and the fourth high degree, the latter dying. 5 patients with clinical presentations of acute appendicitis. The pathological anatomy was further acute appendicitis, a low-grade neuroendocrine carcinoma. In ileum-cecal region, four of it performed right colectomy. In three were low-grade living and fourth high-grade carcinoma with liver mtts who died. In three of the ileum all were occlusive, carrying out intestinal resections, in two low- and last-grade moderate-grade carcinomas with living liver mtts. The colon tumours were, one ascending with hepatic mtts and right colectomy more liver resections, with pathological anatomy being high-grade carcinoma and another a low-grade descending colon. The 6 pancreas lesions, 3 were non-functioning and three other functioning. All patients were operated of CPD. Conclusion: TNE-GEP is a rare pathology but whose frequency is constant onset. With improved imaging methods, we are faced with an increase in preoperative presumption and in the face of its best oncological possibilities, a pathology that every surgeon must know and think about. VL - 9 IS - 4 ER -